HHS to Pick Drugs Subject to Medicare Price Negotiations by September

January 12, 2023

In an announcement this week, the US Department of Health and Human Services has revealed its schedule for the leadup to Medicare drug price negotiations, as granted by the Inflation Reduction Act. While negotiations don’t commence until 2026, the list of 10 drugs to be negotiated will be released in early September, with a public comment phase this spring.

According to Christopher Newman, “CMS will publish a list of the first 10 drugs selected by Sept. 1, 2023, followed by negotiations lasting from February to August 2024. Agreed-upon prices will be released on Oct. 1, 2024. The law directs CMS to focus on single-supplier drugs that account for the highest spending in Medicare.”

To read more, click here.

(Source: BioPharma Dive, January 11th, 2023)

Share This Story!